These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3306837)

  • 21. Gross cystic disease fluid protein (GCDFP-15) in the breast: past and present.
    Sapino A; Cassoni P; Bussolati G
    J Biol Regul Homeost Agents; 2000; 14(4):259-62. PubMed ID: 11215813
    [No Abstract]   [Full Text] [Related]  

  • 22. Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells.
    Cassoni P; Sapino A; Haagensen DE; Naldoni C; Bussolati G
    Int J Cancer; 1995 Jan; 60(2):216-20. PubMed ID: 7829219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor markers for breast carcinoma.
    Haagensen DE
    Clin Lab Med; 1982 Sep; 2(3):543-65. PubMed ID: 6754225
    [No Abstract]   [Full Text] [Related]  

  • 24. Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach.
    Caputo E; Camarca A; Moharram R; Tornatore P; Thatcher B; Guardiola J; Martin BM
    Biochemistry; 2003 May; 42(20):6169-78. PubMed ID: 12755619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of tissue- and hormone-specific regulation of the human prolactin-inducible protein/gross cystic disease fluid protein-15 gene in transgenic mice.
    Myal Y; Iwasiow B; Cosby H; Yarmill A; Blanchard A; Tsuyuki D; Fresnoza A; Duckworth ML; Shiu RP
    J Mol Endocrinol; 1998 Oct; 21(2):217-23. PubMed ID: 9801465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells.
    Simard J; Hatton AC; Labrie C; Dauvois S; Zhao HF; Haagensen DE; Labrie F
    Mol Endocrinol; 1989 Apr; 3(4):694-702. PubMed ID: 2725533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The immunopathology of gross cystic disease fluid proteins.
    Mazoujian G; Haagensen DE
    Ann N Y Acad Sci; 1990; 586():188-97. PubMed ID: 2357000
    [No Abstract]   [Full Text] [Related]  

  • 28. [Symposium: New markers in hormone-dependent cancers].
    Ann Endocrinol (Paris); 1985; 46(4-5):325-41. PubMed ID: 3837633
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunohistochemical stains for breast cancer.
    Roche PC
    Mayo Clin Proc; 1994 Jan; 69(1):57-8. PubMed ID: 8271853
    [No Abstract]   [Full Text] [Related]  

  • 30. Prolactin: the forgotten hormone of human breast cancer.
    Vonderhaar BK
    Pharmacol Ther; 1998 Aug; 79(2):169-78. PubMed ID: 9749881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids.
    Hackenberg R; Schulz KD
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):113-7. PubMed ID: 8603031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Products of exocrine secretion of the breast and breast cancer].
    Franchimont P; Collette J; Zangerle PF; Hendrick JC
    Ann Med Interne (Paris); 1984; 135(5):385-9. PubMed ID: 6486618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tamoxifen in breast cancer.
    Anand A
    Hosp Pract (Off Ed); 1993 Jun; 28(6):17. PubMed ID: 8509477
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody sources.
    Mazoujian G
    Am J Surg Pathol; 1991 Dec; 15(12):1207-8. PubMed ID: 1660678
    [No Abstract]   [Full Text] [Related]  

  • 35. Morphologic and functional aspects of apocrine metaplasia in dysplastic and neoplastic breast tissue.
    Bussolati G; Cattani MG; Gugliotta P; Patriarca E; Eusebi V
    Ann N Y Acad Sci; 1986; 464():262-74. PubMed ID: 3524352
    [No Abstract]   [Full Text] [Related]  

  • 36. Estrogen and progesterone receptors in breast cancer.
    Couch P
    Am J Dermatopathol; 1997 Oct; 19(5):553-5. PubMed ID: 9335253
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification and androgen regulation of two proteins released by T47D human breast cancer cells.
    Chalbos D; Haagensen D; Parish T; Rochefort H
    Cancer Res; 1987 Jun; 47(11):2787-92. PubMed ID: 3567903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer.
    Dumont M; Dauvois S; Simard J; Garcia T; Schachter B; Labrie F
    J Steroid Biochem; 1989; 34(1-6):397-402. PubMed ID: 2626033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
    Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
    Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of hormonal therapy in patients with metastatic breast carcinoma by plasma marker protein profiles.
    Haagensen DE; Dilley WG; Cox CE; Giannola JE; Wells SA
    Surg Forum; 1978; 29():162-4. PubMed ID: 401123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.